HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combined usage of inhaled and intravenous milrinone in pulmonary hypertension after heart valve surgery.

Abstract
Secondary pulmonary hypertension is a frequent condition after heart valve surgery. It may significantly complicate the perioperative management and increase patients' morbidity and mortality. The treatment has not been yet completely defined principally because of lack of the selectivity of drugs for the pulmonary vasculature. The usage of inhaled milrinone could be the possible therapeutic option. Inodilator milrinone is commonly used intravenously for patients with pulmonary hypertension and ventricular dysfunction in cardiac surgery. The decrease in systemic vascular resistance frequently necessitates concomitant use of norepinephrine. Pulmonary vasodilators might be more effective and also devoid of potentially dangerous systemic side effects if applied by inhalation, thus acting predominantly on pulmonary circulation. There are only few reports of inhaled milrinone usage in adult post cardiac surgical patients. We reported 2 patients with severe pulmonary hypertension after valve surgery. Because of desperate clinical situation, we decided to use the combination of inhaled and intravenous milrinone. Inhaled milrinone was delivered by means of pneumatic medication nebulizer dissolved with saline in final concentration of 0.5 mg/ml. The nebulizer was attached to the inspiratory limb of the ventilator circuit, just before the Y-piece. We obtained satisfactory reduction in mean pulmonary artery pressure in both patients, and they were successfully extubated and discharged. Although it is a very small sample of patients, we conclude that the combination of inhaled and intravenous milrinone could be an effective treatment of secondary pulmonary hypertension in high-risk cardiac valve surgery patient. The exact indications for inhaled milrinone usage, optimal concentrations for this route, and the beginning and duration of treatment are yet to be determined.
AuthorsMladen Carev, Cristijan Bulat, Nenad Karanović, Mihajlo Lojpur, Antonio Jercić, Denis Nenadić, Zlatko Marovih, Ino Husedzinović, Dalibor Letica
JournalCollegium antropologicum (Coll Antropol) Vol. 34 Issue 3 Pg. 1113-7 (Sep 2010) ISSN: 0350-6134 [Print] Croatia
PMID20977113 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Milrinone
Topics
  • Administration, Inhalation
  • Aortic Valve (surgery)
  • Female
  • Heart Valve Prosthesis Implantation (adverse effects)
  • Humans
  • Hypertension, Pulmonary (drug therapy)
  • Injections, Intravenous
  • Middle Aged
  • Milrinone (administration & dosage)
  • Mitral Valve (surgery)
  • Postoperative Complications (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: